Skip to main content

CORRECTION article

Front. Neurol., 14 September 2022
Sec. Movement Disorders
Volume 13 - 2022 | https://doi.org/10.3389/fneur.2022.1015572

Corrigendum: Clinical spectrum of tauopathies

\nNahid Olfati,Nahid Olfati1,2Ali ShoeibiAli Shoeibi1Irene Litvan Irene Litvan2*
  • 1Department of Neurology, Faculty of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran
  • 2UC San Diego Department of Neurosciences, Parkinson and Other Movement Disorder Center, San Diego, CA, United States

A corrigendum on
Clinical spectrum of tauopathies

by Olfati, N., Shoeibi, A., and Litvan, I. (2022). Front. Neurol. 13:944806. doi: 10.3389/fneur.2022.944806

In the published article, there was an error in Table 2 as published. Subheading rows of the table, indicating the name of each criteria set, were not shown in the proper format. Additionally, a subheading row showing the title of each clinical category, including nfaPPA, svPPA, and lvPPA, under “Gorno-Tempini PPA criteria” was missing. The corrected Table 2 and its caption appear below.

TABLE 2
www.frontiersin.org

Table 2. Standardized clinical diagnostic criteria of phenotypes related to primary tauopathies based on Movement Disorders Society Progressive Supranuclear Palsy (MDS-PSP) criteria, (91), Armstrong corticobasal degeneration (CBD) (24) criteria, Gorno-Tempini Primary Progressive Aphasia (PPA) criteria (92), and Rascovsky behavioral variant Frontotemporal Dementia (bvFTD) criteria (93).

The authors apologize for this error and state that this does not change the scientific conclusions of the article in any way. The original article has been updated.

Publisher's note

All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.

Keywords: tauopathy, movement, clinical, progressive supranuclear palsy, corticobasal, neurodegenerative, frontotemporal dementia, primary progressive aphasia

Citation: Olfati N, Shoeibi A and Litvan I (2022) Corrigendum: Clinical spectrum of tauopathies. Front. Neurol. 13:1015572. doi: 10.3389/fneur.2022.1015572

Received: 09 August 2022; Accepted: 10 August 2022;
Published: 14 September 2022.

Approved by:

Frontiers Editorial Office, Frontiers Media SA, Switzerland

Copyright © 2022 Olfati, Shoeibi and Litvan. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

*Correspondence: Irene Litvan, ilitvan@health.ucsd.edu

Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.